AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 67 filers reported holding AEROVATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1 | -90.0% | 347 | 0.0% | 0.00% | – |
| Q1 2024 | $10 | -68.8% | 347 | -75.8% | 0.00% | – |
| Q4 2023 | $32 | +52.4% | 1,432 | -6.7% | 0.00% | – |
| Q3 2023 | $21 | -19.2% | 1,535 | 0.0% | 0.00% | – |
| Q2 2023 | $26 | +30.0% | 1,535 | +55.5% | 0.00% | – |
| Q1 2023 | $20 | -42.9% | 987 | -17.7% | 0.00% | – |
| Q4 2022 | $35 | -99.8% | 1,199 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | +5.3% | 1,199 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -29.6% | 1,199 | -18.0% | 0.00% | – |
| Q1 2022 | $27,000 | – | 1,462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 853,330 | $10,061,000 | 4.71% |
| Atlas Venture Life Science Advisors, LLC | 3,103,879 | $36,595,000 | 3.36% |
| OUP Management Co., LLC | 603,762 | $7,118,000 | 3.21% |
| Sofinnova Investments, Inc. | 3,758,686 | $44,315,000 | 2.59% |
| RA Capital Management | 8,263,982 | $97,432,000 | 1.72% |
| Cormorant Asset Management, LP | 1,830,691 | $21,584,000 | 1.28% |
| SECTORAL ASSET MANAGEMENT INC | 282,764 | $3,334,000 | 0.50% |
| Baker Brothers Advisors | 1,831,789 | $21,597,000 | 0.10% |
| Golden State Equity Partners | 15,930 | $188,000 | 0.10% |
| Old Well Partners, LLC | 12,600 | $149,000 | 0.09% |